Juha O Rinne Selected Research

KF18446

1/2021

Effect of dopaminergic medication on adenosine 2A receptor availability in patients with Parkinson's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Juha O Rinne Research Topics

Disease

54	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 12/2002
24	Cognitive Dysfunction 01/2022 - 12/2008
23	Parkinson Disease (Parkinson's Disease) 01/2022 - 10/2002
23	Dementia (Dementias) 01/2022 - 11/2008
15	Neuroinflammatory Diseases 01/2022 - 02/2010
8	Inflammation (Inflammations) 01/2022 - 03/2010
6	Insulin Resistance 04/2021 - 11/2015
5	Atrophy 01/2020 - 11/2008
5	Normal Pressure Hydrocephalus 01/2019 - 12/2012
5	Amyloid Plaque 01/2018 - 02/2010
3	Amyloidosis 01/2018 - 12/2012
3	Disease Progression 01/2018 - 11/2008
2	Type 2 Diabetes Mellitus (MODY) 01/2020 - 01/2017
2	Neurobehavioral Manifestations 01/2018 - 08/2011
2	Epilepsy (Aura) 11/2017 - 01/2017
2	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 01/2016 - 05/2015
2	Frontotemporal Dementia (Semantic Dementia) 01/2016 - 05/2015
2	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2015 - 01/2010
2	Gambling (Pathological Gambling) 05/2012 - 05/2012
2	Overweight 09/2008 - 09/2007
1	Basal Ganglia Diseases (Basal Ganglia Disease) 01/2022
1	Synucleinopathies 01/2022
1	Weight Gain 10/2021
1	Obesity 04/2021
1	Nervous System Diseases (Neurological Disorders) 04/2021
1	Memory Disorders (Memory Loss) 04/2021
1	Brain Diseases (Brain Disorder) 12/2020
1	Tics (Tic) 12/2019
1	Lewy Body Disease (Lewy Body Dementia) 01/2018
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2018
1	Tremor (Tremors) 12/2017
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 12/2017
1	Hypertension (High Blood Pressure) 05/2017
1	Edema (Dropsy) 05/2016
1	Hypoglycemia (Reactive Hypoglycemia) 03/2015

Drug/Important Bio-Agent (IBA)

34	Amyloid (Amyloid Fibrils)IBA 01/2022 - 04/2008
17	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2012
16	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 01/2021 - 01/2008
15	Proteins (Proteins, Gene)FDA Link 01/2021 - 11/2002
14	Glucose (Dextrose)FDA LinkGeneric 10/2021 - 01/2003
13	Apolipoproteins E (ApoE)IBA 01/2022 - 05/2015
12	Amyloid beta-PeptidesIBA 01/2022 - 11/2008
10	Dopamine (Intropin)FDA LinkGeneric 08/2014 - 11/2002
6	flutemetamolIBA 01/2018 - 11/2012
6	Levodopa (L Dopa)FDA LinkGeneric 11/2012 - 10/2002
5	Insulin (Novolin)FDA Link 04/2021 - 03/2015
5	ApolipoproteinsIBA 12/2019 - 09/2004
5	RacloprideIBA 05/2012 - 11/2003
4	Pharmaceutical PreparationsIBA 01/2022 - 07/2006
4	N,N- diethyl- 2- (2- (4- (2- fluoroethoxy)phenyl)- 5,7- dimethylpyrazolo(1,5- a)pyrimidin- 3- yl)acetamideIBA 01/2022 - 05/2015
3	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 04/2021 - 08/2017
3	EnzymesIBA 01/2021 - 09/2004
3	Cholinergic Agents (Cholinergics)IBA 01/2018 - 12/2002
3	CarbonIBA 01/2017 - 04/2008
3	LigandsIBA 01/2017 - 03/2010
3	bapineuzumabIBA 05/2016 - 04/2010
3	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 01/2015 - 11/2003
3	fluorodopa F 18IBA 05/2012 - 02/2001
3	AcetylcholinesteraseIBA 01/2012 - 12/2002
3	Deoxyglucose (2 Deoxy D glucose)IBA 12/2009 - 01/2003
2	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2022 - 01/2018
2	C-Reactive ProteinIBA 01/2021 - 01/2017
2	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2021 - 11/2002
2	ORM-12741IBA 12/2020 - 01/2017
2	Indicators and Reagents (Reagents)IBA 01/2020 - 01/2003
2	Pemetrexed (MTA)FDA Link 01/2020 - 01/2017
2	Rivastigmine (Exelon)FDA LinkGeneric 01/2018 - 12/2002
2	Monoclonal AntibodiesIBA 08/2012 - 04/2010
1	antineoplaston A10 (A 10)IBA 01/2022
1	CannabinoidsIBA 01/2022
1	EndocannabinoidsIBA 01/2022
1	Hormones (Hormone)IBA 10/2021
1	FluorineIBA 04/2021
1	Cholinergic ReceptorsIBA 01/2021
1	Adenosine (Adenocard)FDA LinkGeneric 01/2021
1	Monoamine Oxidase (MAO)IBA 01/2021
1	4- (N- methylamino)- 4'- (2- (2- (2- fluoroethoxy)ethoxy)ethoxy)stilbeneIBA 01/2021
1	KF18446IBA 01/2021
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 12/2020
1	C-PeptideIBA 01/2020
1	Plasminogen Activators (Plasminogen Activator)IBA 01/2020
1	IronIBA 12/2017
1	LipidsIBA 05/2017
1	Cyclooxygenase InhibitorsIBA 01/2017
1	Lipoxygenase (Lipoxygenase-1)IBA 01/2017
1	Biological ProductsIBA 06/2016
1	ImmunosorbentsIBA 01/2016
1	AZD3241IBA 09/2015
1	Peroxidase (Myeloperoxidase)IBA 09/2015
1	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2015
1	LipopolysaccharidesIBA 04/2015
1	JZL 184IBA 04/2015
1	Interferon-gamma (Interferon, gamma)IBA 04/2015
1	(18F)FEMPAIBA 03/2015
1	Ketamine FDA LinkGeneric 03/2015
1	Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric 03/2015
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 03/2015

Therapy/Procedure

3	Therapeutics 08/2017 - 02/2010
1	Drug Therapy (Chemotherapy) 01/2022
1	Aftercare (After-Treatment) 09/2015